Localizing and Scaling Manufacturing of a Bubble CPAP System for Cost-Efficient Neonatal Respiratory Care

Manufacturing transfer, DFM optimization, and supply chain localization establishing an ISO 13485-compliant ecosystem with improved reliability, reduced costs, and stable production at scale.
USA | Critical Care

Key Impact

  • 20-25% reduction in total device cost through localization and redesign
  • An India-centric supply chain established to reduce import dependency and shorten lead times
  • DFM-driven tooling upgrades and enhanced component reliability
  • Predictable scale-up achieved through dedicated plastics manufacturing infrastructure

Client Overview

  • Geography: USA
  • Market Segment: Neonatal Respiratory Care
  • Engagement Model: Design Transfer, Manufacturing Scale-up & Regulatory Enablement

Business Objective

A leading neonatal care innovator aimed to transition its Bubble CPAP respiratory device into scalable, cost-efficient, and compliant manufacturing ecosystem. The objective was to optimize the design for manufacturability, localize the supply chain, and establish robust tooling, validation, and regulatory frameworks – enabling reliable production, reduced costs, and improved supply chain continuity for neonatal care deployment.

Our Approach

Design for Manufacturability (DFM) Optimization

  • Conducted detailed DFM review to improve part manufacturability and tooling architecture
  • Enhanced process repeatability and reduced defect risks through design refinements
  • Optimized component design to improve reliability and reduce overall production cost

Tooling & Plastics Manufacturing Enablement

  • Developed and validated high-precision molds for medical-grade plastics manufacturing
  • Established robust processes for consistent part quality and scalable output

Regulatory & Compliance Support

  • Supported CDSCO registration and regulatory documentation alignment
  • Integration with QMS for traceability and audit readiness

Scale-Ready Production Framework

  • Validated production processes to enable predictable scale-up
  • Optimized supplier coordination and assembly workflows

Results & Business Impact

  • 20-25% reduction in total device cost through localization and redesign
  • Significant lead time reduction achieved through the India-based supply chain

Scale your medical device with localized supply chains and optimized manufacturing costs

Ask Sygma AI

AI-Powered Assistant

SJ Assistant